Done. Chemosensitization to Carboplatin and Paclitaxel by IAP Inhibitor Debio 1143 in Ovarian Cancer Cell Lines: Signature Identification for Potential Patient Stratification - Debiopharm
Home Drug development Publications Chemosensitization to Carbopla…

Chemosensitization to Carboplatin and Paclitaxel by IAP Inhibitor Debio 1143 in Ovarian Cancer Cell Lines: Signature Identification for Potential Patient Stratification

Presented at EORTC 2016, Munich, Germany

D. Rechavi-Robinson (1) N. Wiedemann (1), C. Schusterbauer (1), S. Rigotti (1), F. Brichory (1), G. Vuagniaux (1)
Debiopharm International SA, Lausanne, Switzerland